Endocrine Society Formalizes Partnership with the Korean Endocrine Society

On April 13, the Endocrine Society and the Korean Endocrine Society (KES) officially entered into a memorandum of Understanding (MOU) during the 12th Seoul International Congress of Endocrinology and Metabolism (SICEM) in conjunction with the 43rd Annual Scientific Meeting of the KES, which took place in Seoul, South Korea, April 11 – 13, 2024.

Incoming Endocrine Society President Society President John Newell-Price, MD, PhD, FRCP, and KES President Yoon-Sok (Martin) Chung, MD, PhD, at the MOU signing at SICEM 2024 in Seoul, Korea, in April.

This MOU was signed to formally recognize the relationship between the two organizations and fulfill the requirements of all participating Global Endocrine Leadership Coalition (GELC) partners who have agreed to work together to support a network of international membership organizations to advance the field of endocrinology.

Taking part in the signing ceremony in Seoul were incoming Endocrine Society President John Newell-Price, MD, PhD, FRCP, and KES President Yoon-Sok (Martin) Chung, MD, PhD. Newell-Price is a professor of endocrinology at the University of Sheffield in Sheffield, U.K., and head of both the Endocrinology Service at the Sheffield Teaching Hospitals NHS Foundation Trust and the European Neuroendocrine Tumor Society. Chung is a professor in the Department of Endocrinology and Metabolism at the Ajou University School of Medicine, and director of the Ajou Institute on Aging at the Ajou University Medical Center, Suwon, South Korea.

“The Global Endocrine Leadership Coalition between the Endocrine Society and other societies globally seeks to create a collaborative network and knowledge exchange to enhance advancement of endocrine science and clinical practice.”

John Newell-Price, MD, PhD, FRCP, professor of endocrinology, University of Sheffield in Sheffield, U.K.; head, Endocrinology Service at the Sheffield Teaching Hospitals NHS Foundation Trust and the European Neuroendocrine Tumor Society; incoming Endocrine Society president

According to Newell-Price, the relationship between the Endocrine Society and the KES was more closely forged by the signing the MOU between the two societies. “Such partnership is vital to the better championing of endocrinology worldwide, this resonating with ‘One Endo’ theme of SICEM 2024,” Newell-Price tells Endocrine News. “The Global Endocrine Leadership Coalition between the Endocrine Society and other societies globally seeks to create a collaborative network and knowledge exchange to enhance advancement of endocrine science and clinical practice, through joint programs and initiatives, educational webinar series, and joint symposia, and by tackling issues that cross borders and affect endocrinology everywhere, including the workforce pipeline.”

At SICEM 2024 in Seoul, Korea, external exhibits lead and marketing specialist John Butler (far right) greets attendees (including KES President Yoon-Sok (Martin) Chung, MD, PhD, second from left) interested to learn more about the Endocrine Society.

The Endocrine Society and the KES in conjunction with the GELC, are committed to uniting endocrine clinicians and scientists worldwide in a collaborative network dedicated to the worldwide advancement of the field of endocrinology, the specialty of endocrinologists, and the promotion of endocrine care, science, and research.

With this MOU, the KES is committed to serving as an active member of the GELC until 2029.

The Endocrine Society welcomes global membership organizations focused on endocrinology and endocrine-related diseases to join the GELC. If your organization is interested in joining the GELC please reach out to [email protected] for more information. 

You may also like

  • Webinar Will Examine Concerns Around Compounding Anti-Obesity Medications

    Endocrine Society to host virtual Science Writers Conference Nov. 14 Surging demand for a new generation of highly effective anti-obesity medications is creating interest in compounded versions of these medications. Endocrine Society experts will discuss the importance of prescribing FDA-approved medications to treat obesity during the Society’s Virtual Science Writers Conference on November 14. What:…

  • Bianco Named Vice President and Vice Provost for Research, Chief Research Officer at UTMB

    Antonio Bianco, MD, PhD, has joined the University of Texas Medical Branch (UTMB) as vice president and vice provost, research, and chief research officer, effective Sept. 1. A renowned physician-scientist, scholar, and research leader, Bianco possesses an impressive academic career that includes influential contributions to the field of thyroid diseases and an enduring commitment to…

Find more in